FDA review details use of manufacturing process models in drug applications - RAPS
FDA has detailed the use of manufacturing process models in drug applications, impacting how drug manufacturers submit applications.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on September 7, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, compounding outsourcing (503B). should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New guidelines on the incorporation of manufacturing process models in drug applications.
Who it affects
Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, compounding outsourcing (503B).
What you must do
Review and potentially revise drug application submissions to align with the new FDA guidelines.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- FDA on the Offense! Targeting Pharmaceutical Company Drug Advertising in Wave of Enforcement Actions - natlawreview.com
- House Republican introduces bill that would essentially nullify Nessel’s insulin price gouging suit - michiganadvance.com
- Governor signs bill requiring informed consent for nursing home patients for prescription of antipsychotic drugs - oksenate.gov
- Company prohibited from distributing drug products - The Journal Record
- Trump Approves Final Plan to Import Drugs From Canada ‘for a Fraction of the Price’ - kffhealthnews.org